Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-LYPD3 Antibody-APC (5Y943)
😃Good
Catalog No. TMAY-02083A
Alias LY6/PLAUR domain containing 3, C4.4A
Anti-LYPD3 Antibody-APC (5Y943) is a APC-conjugated Rabbit antibody targeting LYPD3. Anti-LYPD3 Antibody-APC (5Y943) can be used in FCM.
Anti-LYPD3 Antibody-APC (5Y943)
Anti-LYPD3 Antibody-APC (5Y943)
😃Good
Catalog No. TMAY-02083AAlias LY6/PLAUR domain containing 3, C4.4A
Anti-LYPD3 Antibody-APC (5Y943) is a APC-conjugated Rabbit antibody targeting LYPD3. Anti-LYPD3 Antibody-APC (5Y943) can be used in FCM.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 T | $127 | 7-10 days | |
| 100 T | $257 | 7-10 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Antibody Type: Rabbit Monoclonal Application: FCM Reactivity: Human |
| Alias | LY6/PLAUR domain containing 3, C4.4A |
| Ig Type | Rabbit IgG |
| Clone | 5Y943 |
| Reactivity | Human |
| Verified Activity | Flow cytometric analysis of Human LYPD3 expression on PC-3 cells. |
| Application | FCM |
| Recommended Dose | 10 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human C4.4A / LYPD3 (rh C4.4A / LYPD3; TMPY-01859; NP_055215.2; Met1-His286) and conjugated with APC under optimum conditions, the unreacted APC was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
| Research Background | Ly6 / PLAUR domain-containing protein 3, also known as GPI-anchored metastasis-associated protein C4.4A homolog, Matrigel-induced gene C4 protein, MIG-C4, and LYPD3, is a cell membrane protein that contains two UPAR/Ly6 domains. Human LYPD3 contains two UPAR/Ly6 domains. LYPD3 is expressed in the placenta, skin, and urothelium. It is found in suprabasal keratinocytes of chronic wounds. Weak expression of LYPD3 is found in the esophagus and peripheral blood mononuclear cells. It is found in the majority of primary and metastatic transitional cell carcinomas (TCCs) and as well in breast cancer tissues, but not in adjacent normal tissues. High expression of LYPD3 is found in the tumor component of some noninvasive superficial lesions and invasive and metastatic urothelial cancers. LYPD3 is up-regulated in migrating keratinocytes during epithelisation of incisional skin wounds. LYPD3 supports cell migration. It may be involved in urothelial cell-matrix interactions. It may also be involved in tumor progression |
| Conjucates | APC |
| Others Formats | Unconjugated/PE |
| Antibody Types Available | 3 |
| Immunogen | Recombinant Protein: Human C4.4A / LYPD3 protein (TMPY-01859) |
| Antigen Species | Human |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-LYPD3 Antibody-APC (5Y943) | purchase Anti-LYPD3 Antibody-APC (5Y943) | Anti-LYPD3 Antibody-APC (5Y943) cost | order Anti-LYPD3 Antibody-APC (5Y943)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.